|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.157 EUR | -0.76% |
|
-4.73% | -21.34% |
| 07-16 | SpineGuard: growth accelerates in Q2 | CF |
| 07-15 | SpineGuard SA Reports Consolidated Revenue Results for the Second Quarter and First Half of 2024 | CI |
SpineGuard announced unaudited consolidated revenue results for the full year of 2013. For the period, the company reported revenue of EUR 4,615,000 against EUR 3,877,000 a year ago period. Revenue totaled EUR 3,369,000 (+19% CC) in the United States and EUR 1,247,000 (+22% CC) in the rest of the world representing 3,142 and 3,166 units sold, respectively, and a total of 6,308 PediGuard.
30,000 surgical procedures have been performed with PediGuard since its introduction.
| 1st Jan change | Capi. | |
|---|---|---|
| -21.34% | 9.13M | |
| +75.69% | 12.57B | |
| -21.78% | 7.63B | |
| -6.25% | 5.84B | |
| +8.16% | 5.16B | |
| -17.37% | 4.75B | |
| +16.22% | 4.16B | |
| -12.55% | 4.17B | |
| -10.69% | 3.37B | |
| -1.98% | 1.99B |
SPINEGUARD 
